Brief: Seoul Pharma appoints CEO
Aug 9 (Reuters) - Seoul Pharma Co Ltd 018680.KQ :
* Says it changed CEO of the co to Hwang Woo Sung
Source text in Korean: https://goo.gl/MHNa5c
Further company coverage: 018680.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))
Recent news on Seoul Pharma
See all newsBrief: Seoul Pharma Says Terminates Contract Worth $5.3 Million To Supply Erectile Dysfunction Drugs In Middle East Region
Brief: Seoul Pharma appoints CEO
Brief: Seoul Pharma issues 3rd tranche convertible bonds worth 6 bln won
Brief: Seoul Pharma signs contract worth 7.86 bln won
Brief: Seoul Pharma signs contract worth 8.62 bln won